DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 2,008 filers reported holding DANAHER CORPORATION in Q1 2022. The put-call ratio across all filers is 1.38 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $8,285,796 | -1.6% | 33,397 | -4.8% | 4.06% | +8.6% |
| Q2 2023 | $8,423,280 | -2.6% | 35,097 | +2.3% | 3.74% | -9.5% |
| Q1 2023 | $8,644,215 | -4.8% | 34,297 | +0.3% | 4.13% | -9.9% |
| Q4 2022 | $9,076,568 | -5.8% | 34,197 | -8.3% | 4.59% | -11.7% |
| Q3 2022 | $9,634,000 | +1.9% | 37,299 | +0.0% | 5.19% | +9.1% |
| Q2 2022 | $9,456,000 | -14.5% | 37,298 | -1.0% | 4.76% | +16.4% |
| Q1 2022 | $11,055,000 | -12.6% | 37,686 | -2.0% | 4.09% | +0.0% |
| Q4 2021 | $12,646,000 | +1.4% | 38,436 | -6.2% | 4.08% | -4.5% |
| Q3 2021 | $12,469,000 | +13.4% | 40,956 | -0.1% | 4.28% | +10.2% |
| Q2 2021 | $10,999,000 | +19.7% | 40,986 | +0.4% | 3.88% | +10.5% |
| Q1 2021 | $9,191,000 | +0.1% | 40,836 | -1.2% | 3.51% | -3.8% |
| Q4 2020 | $9,182,000 | +0.7% | 41,336 | -2.4% | 3.65% | -12.4% |
| Q3 2020 | $9,116,000 | +21.8% | 42,336 | 0.0% | 4.17% | +12.5% |
| Q2 2020 | $7,486,000 | +21.2% | 42,336 | -5.2% | 3.70% | +4.5% |
| Q1 2020 | $6,178,000 | -17.2% | 44,636 | -8.2% | 3.54% | +6.8% |
| Q4 2019 | $7,465,000 | +3.6% | 48,636 | -2.5% | 3.32% | -3.4% |
| Q3 2019 | $7,205,000 | +3.3% | 49,886 | +2.3% | 3.43% | +7.8% |
| Q2 2019 | $6,972,000 | +7.7% | 48,785 | -0.5% | 3.18% | -0.0% |
| Q1 2019 | $6,473,000 | +42.5% | 49,035 | +11.4% | 3.18% | +12.6% |
| Q4 2018 | $4,541,000 | +8.5% | 44,035 | +14.3% | 2.83% | +47.1% |
| Q3 2018 | $4,187,000 | +9.7% | 38,535 | -0.4% | 1.92% | -4.4% |
| Q2 2018 | $3,816,000 | +1.2% | 38,675 | +0.4% | 2.01% | +1.6% |
| Q1 2018 | $3,772,000 | +15.1% | 38,530 | +9.1% | 1.98% | +17.6% |
| Q4 2017 | $3,277,000 | +8.0% | 35,305 | -0.2% | 1.68% | +7.9% |
| Q3 2017 | $3,035,000 | +1.1% | 35,380 | -0.6% | 1.56% | -6.0% |
| Q2 2017 | $3,003,000 | +0.9% | 35,580 | +2.3% | 1.66% | -7.2% |
| Q1 2017 | $2,975,000 | +8.6% | 34,780 | -1.1% | 1.79% | +0.3% |
| Q4 2016 | $2,739,000 | +0.7% | 35,180 | +1.4% | 1.78% | +5.4% |
| Q3 2016 | $2,719,000 | -22.4% | 34,680 | 0.0% | 1.69% | -25.9% |
| Q2 2016 | $3,502,000 | +6.4% | 34,680 | 0.0% | 2.28% | +7.6% |
| Q1 2016 | $3,290,000 | +1.9% | 34,680 | -0.3% | 2.12% | -5.5% |
| Q4 2015 | $3,230,000 | +9.0% | 34,780 | 0.0% | 2.24% | -4.8% |
| Q3 2015 | $2,964,000 | -0.2% | 34,780 | +0.3% | 2.36% | +21.2% |
| Q2 2015 | $2,969,000 | +0.8% | 34,680 | 0.0% | 1.94% | +2.6% |
| Q1 2015 | $2,945,000 | +0.5% | 34,680 | -10.0% | 1.90% | -5.8% |
| Q4 2014 | $2,930,000 | +0.1% | 38,530 | 0.0% | 2.01% | -2.7% |
| Q3 2014 | $2,927,000 | +6.4% | 38,530 | +10.3% | 2.07% | +14.7% |
| Q2 2014 | $2,750,000 | +5.3% | 34,930 | +0.3% | 1.80% | -4.9% |
| Q1 2014 | $2,612,000 | -2.7% | 34,830 | +0.1% | 1.90% | +0.2% |
| Q4 2013 | $2,685,000 | +12.0% | 34,780 | +0.6% | 1.89% | -2.8% |
| Q3 2013 | $2,397,000 | +9.5% | 34,580 | 0.0% | 1.95% | -7.5% |
| Q2 2013 | $2,189,000 | – | 34,580 | – | 2.11% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Defender Capital, LLC. | 149,732 | $49,263,000 | 15.79% |
| ARTHUR M. COHEN & ASSOCIATES, LLC | 257,846 | $84,834,000 | 15.76% |
| Riverstone Advisors, LLC | 64,448 | $21,204,000 | 9.33% |
| Eos Focused Equity Management, L.P. | 34,026 | $11,195,000 | 8.72% |
| Mirova US LLC | 1,152,609 | $379,219,000 | 7.12% |
| Lincoln Capital LLC | 83,275 | $27,398,000 | 6.78% |
| CORTLAND ASSOCIATES INC/MO | 197,469 | $64,969,000 | 6.75% |
| Third Point | 2,900,000 | $954,129,000 | 6.66% |
| Front Street Capital Management, Inc. | 117,523 | $36,073,000 | 6.65% |
| Alphinity Investment Management Pty Ltd | 865,427 | $284,734,000 | 6.40% |